Rey E, Talley NJ: Irritable bowel syndrome: novel views on the epidemiology and potential risk factors. Dig Liver Dis. 2009, 41: 772-780. 10.1016/j.dld.2009.07.005.
Article
CAS
PubMed
Google Scholar
Rajendra S, Alahuddin S: Prevalence of irritable bowel syndrome in a multi-ethnic Asian population. Aliment Pharmacol Ther. 2004, 19: 704-706. 10.1111/j.1365-2036.2004.01891.x.
Article
CAS
PubMed
Google Scholar
Tan YM, Goh KL, Muhidayah R, Ooi CL, Salem O: Prevalence of irritable bowel syndrome in young adult Malaysians: a survey among medical students. J Gastroenterol Hepatol. 2003, 18: 1412-1416. 10.1046/j.1440-1746.2003.03212.x.
Article
PubMed
Google Scholar
Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC: Functional bowel disorders. Gastroenterology. 2006, 130: 1480-1491. 10.1053/j.gastro.2005.11.061.
Article
PubMed
Google Scholar
Barbara G, De Giorgio R, Stanghellini V, Cremon C, Salvioli B, Corinaldesi R: New pathophysiological mechanisms in irritable bowel syndrome. Aliment Pharmacol Ther. 2004, 20 (Suppl 2): 1-9.
Article
PubMed
Google Scholar
Talley NJ: Irritable bowel syndrome. Intern Med J. 2006, 36: 724-728. 10.1111/j.1445-5994.2006.01217.x.
Article
CAS
PubMed
PubMed Central
Google Scholar
Barbara G, Cremon C, Carini G, Bellacosa L, Zecchi L, De Giorgio R, Corinaldesi R, Stanghellini V: The immune system in irritable bowel syndrome. J Neurogastroenterol Motil. 2011, 17: 349-359. 10.5056/jnm.2011.17.4.349.
Article
PubMed
PubMed Central
Google Scholar
Liebregts T, Adam B, Bredack C, Roth A, Heinzel S, Lester S, Downie-Doyle S, Smith E, Drew P, Talley NJ: Immune activation in patients with irritable bowel syndrome. Gastroenterology. 2007, 132: 913-920. 10.1053/j.gastro.2007.01.046.
Article
CAS
PubMed
Google Scholar
Spiller R, Campbell E: Post-infectious irritable bowel syndrome. Curr Opin Gastroenterol. 2006, 22: 13-17. 10.1097/01.mog.0000194792.36466.5c.
Article
PubMed
Google Scholar
Barbara G, De Giorgio R, Stanghellini V, Cremon C, Corinaldesi R: A role for inflammation in irritable bowel syndrome?. Gut. 2002, 51 (Suppl 1): i41-i44.
Article
PubMed
PubMed Central
Google Scholar
Spiller R, Garsed K: Infection, inflammation, and the irritable bowel syndrome. Dig Liver Dis. 2009, 41: 844-849. 10.1016/j.dld.2009.07.007.
Article
CAS
PubMed
Google Scholar
Gwee KA: Post-Infectious Irritable Bowel Syndrome, an Inflammation-Immunological Model with Relevance for Other IBS and Functional Dyspepsia. J Neurogastroenterol Motil. 2010, 16: 30-34. 10.5056/jnm.2010.16.1.30.
Article
PubMed
PubMed Central
Google Scholar
Akiho H, Ihara E, Nakamura K: Low-grade inflammation plays a pivotal role in gastrointestinal dysfunction in irritable bowel syndrome. World J Gastrointest Pathophysiol. 2010, 1: 97-105. 10.4291/wjgp.v1.i3.97.
Article
PubMed
PubMed Central
Google Scholar
Ford AC, Talley NJ: Mucosal inflammation as a potential etiological factor in irritable bowel syndrome: a systematic review. J Gastroenterol. 2011, 46: 421-431. 10.1007/s00535-011-0379-9.
Article
PubMed
Google Scholar
Pardi DS, Kelly CP: Microscopic colitis. Gastroenterology. 2011, 140: 1155-1165. 10.1053/j.gastro.2011.02.003.
Article
PubMed
Google Scholar
Limsui D, Pardi DS, Camilleri M, Loftus EV, Kammer PP, Tremaine WJ, Sandborn WJ: Symptomatic overlap between irritable bowel syndrome and microscopic colitis. Inflamm Bowel Dis. 2007, 13: 175-181. 10.1002/ibd.20059.
Article
PubMed
Google Scholar
Carmona-Sanchez R, Carrera-Alvarez MA, Perez-Aguilar RM: Prevalence of microscopic colitis in patients with irritable bowel syndrome with diarrhea predominance. Rev Gastroenterol Mex. 2011, 76: 39-45.
CAS
PubMed
Google Scholar
Madisch A, Bethke B, Stolte M, Miehlke S: Is there an association of microscopic colitis and irritable bowel syndrome–a subgroup analysis of placebo-controlled trials. World J Gastroenterol. 2005, 11: 6409-
Article
PubMed
PubMed Central
Google Scholar
Baert F, Schmit A, D’Haens G, Dedeurwaerdere F, Louis E, Cabooter M, De Vos M, Fontaine F, Naegels S, Schurmans P: Budesonide in collagenous colitis: a double-blind placebo-controlled trial with histologic follow-up. Gastroenterology. 2002, 122: 20-25. 10.1053/gast.2002.30295.
Article
CAS
PubMed
Google Scholar
Miehlke S, Heymer P, Bethke B, Bastlein E, Meier E, Bartram HP, Wilhelms G, Lehn N, Dorta G, DeLarive J: Budesonide treatment for collagenous colitis: a randomized, double-blind, placebo-controlled, multicenter trial. Gastroenterology. 2002, 123: 978-984. 10.1053/gast.2002.36042.
Article
CAS
PubMed
Google Scholar
Miehlke S, Madisch A, Bethke B, Morgner A, Kuhlisch E, Henker C, Vogel G, Andersen M, Meier E, Baretton G: Oral budesonide for maintenance treatment of collagenous colitis: a randomized, double-blind, placebo-controlled trial. Gastroenterology. 2008, 135: 1510-1516. 10.1053/j.gastro.2008.07.081.
Article
CAS
PubMed
Google Scholar
Miehlke S, Madisch A, Karimi D, Wonschik S, Kuhlisch E, Beckmann R, Morgner A, Mueller R, Greinwald R, Seitz G: Budesonide is effective in treating lymphocytic colitis: a randomized double-blind placebo-controlled study. Gastroenterology. 2009, 136: 2092-2100. 10.1053/j.gastro.2009.02.078.
Article
CAS
PubMed
Google Scholar
Lazenby AJ, Yardley JH, Giardiello FM, Jessurun J, Bayless TM: Lymphocytic (“microscopic”) colitis: a comparative histopathologic study with particular reference to collagenous colitis. Hum Pathol. 1989, 20: 18-28. 10.1016/0046-8177(89)90198-6.
Article
CAS
PubMed
Google Scholar
Falodia S, Makharia GK, Sateesh J, Deo V, Tevatia MS, Gupta SD: Spectrum of microscopic colitis in a tertiary care centre in India. Trop Gastroenterol. 2007, 28: 121-125.
PubMed
Google Scholar
Chadwick VS, Chen W, Shu D, Paulus B, Bethwaite P, Tie A, Wilson I: Activation of the mucosal immune system in irritable bowel syndrome. Gastroenterology. 2002, 122: 1778-1783. 10.1053/gast.2002.33579.
Article
PubMed
Google Scholar
Gwee KA, Collins SM, Read NW, Rajnakova A, Deng Y, Graham JC, McKendrick MW, Moochhala SM: Increased rectal mucosal expression of interleukin 1beta in recently acquired post-infectious irritable bowel syndrome. Gut. 2003, 52: 523-526. 10.1136/gut.52.4.523.
Article
CAS
PubMed
PubMed Central
Google Scholar
Barbara G, Stanghellini V, De Giorgio R, Cremon C, Cottrell GS, Santini D, Pasquinelli G, Morselli-Labate AM, Grady EF, Bunnett NW: Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterology. 2004, 126: 693-702. 10.1053/j.gastro.2003.11.055.
Article
PubMed
Google Scholar
De Silva AP, Nandasiri SD, Hewavisenthi J, Manamperi A, Ariyasinghe MP, Dassanayake AS, Jewell DP, de Silva HJ: Subclinical mucosal inflammation in diarrhea-predominant irritable bowel syndrome (IBS) in a tropical setting. Scand J Gastroenterol. 2012, 47: 619-624.
Article
PubMed
Google Scholar
Quigley EM: Irritable bowel syndrome and inflammatory bowel disease: interrelated diseases?. Chin J Dig Dis. 2005, 6: 122-132. 10.1111/j.1443-9573.2005.00202.x.
Article
PubMed
Google Scholar
Mearin F, Perello A, Balboa A: [Irritable bowel syndrome and inflammatory bowel disease: Is there a connection?]. Gastroenterol Hepatol. 2009, 32: 364-372. 10.1016/j.gastrohep.2008.12.007.
Article
PubMed
Google Scholar
Dorofeyev AE, Kiriyan EA, Vasilenko IV, Rassokhina OA, Elin AF: Clinical, endoscopical and morphological efficacy of mesalazine in patients with irritable bowel syndrome. Clin Exp Gastroenterol. 2011, 4: 141-153. 10.1007/s12328-011-0219-8.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hanevik K, Dizdar V, Langeland N, Eide GE, Hausken T: Tolerability and effect of mesalazine in postinfectious irritable bowel syndrome. Aliment Pharmacol Ther. 2011, 34: 259-260. 10.1111/j.1365-2036.2011.04715.x.
Article
CAS
PubMed
Google Scholar
Bafutto M, Almeida JR, Leite NV, Oliveira EC, Gabriel-Neto S, Rezende-Filho J: Treatment of postinfectious irritable bowel syndrome and noninfective irritable bowel syndrome with mesalazine. Arq Gastroenterol. 2011, 48: 36-40. 10.1590/S0004-28032011000100008.
Article
PubMed
Google Scholar
Corinaldesi R, Stanghellini V, Cremon C, Gargano L, Cogliandro RF, De Giorgio R, Bartesaghi G, Canovi B, Barbara G: Effect of mesalazine on mucosal immune biomarkers in irritable bowel syndrome: a randomized controlled proof-of-concept study. Aliment Pharmacol Ther. 2009, 30: 245-252. 10.1111/j.1365-2036.2009.04041.x.
Article
CAS
PubMed
Google Scholar
Chey WD, Nojkov B, Rubenstein JH, Dobhan RR, Greenson JK, Cash BD: The yield of colonoscopy in patients with non-constipated irritable bowel syndrome: results from a prospective, controlled US trial. Am J Gastroenterol. 2010, 105: 859-865. 10.1038/ajg.2010.55.
Article
PubMed
PubMed Central
Google Scholar
Malaysia National Specialist Register. [http://www.nsr.org.my/]
Mohamed N, Marais M, Bezuidenhout J: Microscopic colitis as a missed cause of chronic diarrhea. World J Gastroenterol. 2011, 17: 1996-2002. 10.3748/wjg.v17.i15.1996.
Article
PubMed
PubMed Central
Google Scholar